Frameworks for Digital Advertising
Standards in Medicine.

China · Advertising framework

Online video advertising for food supplements in China

General market orientation, not campaign clearance. Research scope and dates

Product and service rules

Health food is not interchangeable with an ordinary supplement category

Legal requirement — paraphrased

Determine whether the product is health food, ordinary food, a medicine or another category. Health-food advertising requires review and the prescribed identification and statements, including that it is not a substitute for medicine. Claims must follow the approved or filed scope and cannot promise disease prevention or treatment.

Sources: SAMR Order 21 — regulated product advertising review; Advertising Law of the People’s Republic of China

Advertising identification does not permit a prohibited endorsement

Legal requirement — paraphrased

Medical, drug, device and health-food advertisements have specific restrictions on endorsement and recommendation. Do not use an influencer, patient or health professional to validate efficacy where that recommendation is prohibited. A commercial label cannot cure the prohibited substance of the message.

Sources: Advertising Law of the People’s Republic of China; SAMR Order 21 — regulated product advertising review

Track approval expiry and the approved creative version

Legal requirement — paraphrased

Under Order 21, advertising approval expires with the earliest relevant underlying product or production document; where those documents have no expiry, the advertising approval lasts two years. Changes to approved content require renewed review. Do not treat a shortened or rearranged video as automatically covered by the original approval.

Sources: SAMR Order 21 — regulated product advertising review

Keep the applicable warning visible throughout video

Legal requirement — paraphrased

SAMR Order 21 requires category-specific warnings and the advertising approval number. OTC ads need the OTC symbol and the instruction to purchase/use according to the leaflet or pharmacist guidance; personal-use devices have their own instruction and applicable contraindication notice. Health-food ads must state that the product is not a medicine and cannot replace medicine for disease treatment, and identify suitable and unsuitable users. Required prominent information must remain visible throughout video, with clear type and colour.

Sources: SAMR Order 21 — regulated product advertising review · Articles 5–10; use the exact Chinese wording from the approved creative.

Channel rules

Check the complete consumer-facing message

Regulator guidance

Advertising must be truthful and clear. Review the accuracy of stated functions, benefits, provider details, prices and promises under the Advertising Law. Sector review requirements and prohibited claims continue to apply even when the advertiser identifies the commercial nature of a message.

Sources: Advertising Law of the People’s Republic of China

Do not disguise regulated advertising as health education

Legal requirement — paraphrased

Reviewed health advertisements must remain within the approved content. Internet rules prohibit disguised medical, medicine, device and health-food advertisements presented as health knowledge; related supplier contacts or shopping links alongside that knowledge are specifically restricted. Paid search needs clear advertising identification.

Sources: Internet Advertising Measures, SAMR Order 72

Health information and automated marketing need separate review

Legal requirement — paraphrased

PIPL treats medical and health information as sensitive personal information, with heightened necessity and protection requirements. Assess applicable separate-consent obligations and the limited non-consent bases. Automated commercial marketing must provide the required non-personalised option or convenient refusal route; check cross-border data flows separately.

Sources: Personal Information Protection Law

Do not apply the ordinary-data threshold to health data

Regulator guidance

The CAC identifies medical and health information as sensitive personal information. Its under-100,000-person ordinary-data exemption excludes sensitive data. Subject to stated exemptions, a non-critical-infrastructure operator exporting sensitive information for fewer than 10,000 people must use the standard-contract or certification route; at least 10,000 requires a security assessment. Important data and critical-infrastructure operators have separate assessment triggers. Count people from 1 January and document the specific exemption, if any; an advertising consent checkbox does not establish a transfer mechanism.

Sources: Cross-border data provisions — official explanatory FAQ

Approve the final audiovisual edit

Editorial recommendation

Review speech, captions, demonstrations, overlay visibility and playback speed. Recheck short edits and silent versions against applicable product warning and disclosure requirements.

Exclude restricted health and beauty ads from media directed at minors

Legal requirement — paraphrased

Applies when: The internet medium is directed at minors and the advertisement falls within an Article 12 sector.

Article 12 prohibits medical, medicine, medical-device, health-food, special-medical-purpose food, cosmetic and beauty advertising on internet media directed at minors. The restriction concerns the medium’s audience and context, not only a chosen targeting checkbox.

First classify the advertised offer within the listed sectors; ordinary wellness content is not automatically a regulated product advertisement.

Sources: Internet Advertising Measures — official HTML text

Campaign workflow

Food Supplements: prepare the review

Editorial recommendation

Determine whether the local category is food, natural health product, medicine or another regulated class. Match each claim to the local permitted or notified wording and its composition and use conditions. Assess captions, testimonials and images for an implied treatment or prevention claim.

Keep a traceable campaign decision

Editorial recommendation

Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.

Pre-publication checklist

  • Determine whether the local category is food, natural health product, medicine or another regulated class.
  • Match each claim to the local permitted or notified wording and its composition and use conditions.
  • Assess captions, testimonials and images for an implied treatment or prevention claim.
  • Record product or provider eligibility before approving claims.
  • Archive the final creative and its evidence, permissions and review decisions.
  • Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.

Scope and unresolved questions

  • Mainland only. Beijing TCM review, national online-retail display conditions, warning presentation and a cross-border data route are documented. Other provincial filing procedures, actual seller permissions, platform account rules, product-specific Chinese assets and the transfer facts still require review.
  • This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates

Food-supplement promotion in online videos in China begins with local classification. A product sold as a supplement elsewhere may follow a different health-product route here; check the applicable claim conditions before adapting testimonials or benefit statements.

A video combines sound, images, captions and timing. Review the full edit and each short-form excerpt, allowing for the relevant warning or disclosure presentation and the possibility that a silent version needs a separate format assessment.

Sources checked 2026-10-24 · Editorial research · Legal review pending

General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.

Coverage: National baseline and category-specific review routes; not an exhaustive compliance opinion

How to use this national baseline

Editorial overview

This framework combines researched national rules with editorial review steps. Mainland China only; Hong Kong, Macau and Taiwan are outside this pack. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.

The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.

Your next step: choose a local partner

Use this framework to brief qualified local legal and regulatory specialists. Ask them to verify current requirements and assess your specific product, service and campaign before acting.

Sources

  1. SAMR Order 21 — regulated product advertising review

    State Administration for Market Regulation · legislation · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  2. Advertising Law of the People’s Republic of China

    SAMR · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  3. Internet Advertising Measures, SAMR Order 72

    SAMR · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  4. Personal Information Protection Law

    National People’s Congress, official MIIT publication · legislation · checked 2026-10-24

    Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.

  5. Cross-border data provisions — official explanatory FAQ

    Cyberspace Administration of China · regulator guidance · checked 2026-10-25

    Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.

  6. Internet Advertising Measures — official HTML text

    SAMR · legislation · checked 2026-10-25

    Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.

From framework to action

Local expertise in China

Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in China.

Medical & health marketing

No partners listed in this category yet.

Marketing & sales advisory

No partners listed in this category yet.

Business & project coordination

No partners listed in this category yet.

Browse partners in China

Join the local partner directory

Would you like your company to be listed?

Talk to us about the terms of a listing. Leave your details and we will get in touch.

Publicity@fdasm.com

Contact details for a partner listing enquiry

We use your details to respond to your enquiry and discuss a listing. Submitting the form does not automatically add your company to the directory. Read our Privacy & cookies policy. Privacy contact: Publicity@fdasm.com.